Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of CHF 218.90 billion. The enterprise value is 251.40 billion.

Market Cap	218.90B
Enterprise Value	251.40B

Important Dates

The last earnings date was Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.80%
Shares Change (QoQ)	-0.67%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	43.83%
Float	1.82B

Valuation Ratios

The trailing PE ratio is 20.16 and the forward PE ratio is 16.20.

PE Ratio	20.16
Forward PE	16.20
PS Ratio	4.82
PB Ratio	7.01
P/TBV Ratio	n/a
P/FCF Ratio	15.56
P/OCF Ratio	14.23
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.36, with an EV/FCF ratio of 17.87.

EV / Earnings	23.16
EV / Sales	5.59
EV / EBITDA	13.36
EV / EBIT	16.69
EV / FCF	17.87

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 1.21.

Current Ratio	0.85
Quick Ratio	0.53
Debt / Equity	1.21
Debt / EBITDA	2.03
Debt / FCF	2.68
Interest Coverage	15.14

Financial Efficiency

Return on equity (ROE) is 34.93% and return on invested capital (ROIC) is 21.10%.

Return on Equity (ROE)	34.93%
Return on Assets (ROA)	10.54%
Return on Invested Capital (ROIC)	21.10%
Return on Capital Employed (ROCE)	21.14%
Weighted Average Cost of Capital (WACC)	6.24%
Revenue Per Employee	602,951
Profits Per Employee	144,232
Employee Count	75,267
Asset Turnover	0.52
Inventory Turnover	2.28

Taxes

In the past 12 months, Novartis AG has paid 1.82 billion in taxes.

Income Tax	1.82B
Effective Tax Rate	14.38%

Stock Price Statistics

The stock price has increased by +21.41% in the last 52 weeks. The beta is 0.49, so Novartis AG's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	+21.41%
50-Day Moving Average	121.92
200-Day Moving Average	108.62
Relative Strength Index (RSI)	34.90
Average Volume (20 Days)	129,950

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of CHF 45.38 billion and earned 10.86 billion in profits. Earnings per share was 5.60.

Revenue	45.38B
Gross Profit	34.29B
Operating Income	14.78B
Pretax Income	12.66B
Net Income	10.86B
EBITDA	18.39B
EBIT	14.78B
Earnings Per Share (EPS)	5.60

Balance Sheet

The company has 5.53 billion in cash and 37.70 billion in debt, giving a net cash position of -32.17 billion.

Cash & Cash Equivalents	5.53B
Total Debt	37.70B
Net Cash	-32.17B
Net Cash Per Share	n/a
Equity (Book Value)	31.22B
Book Value Per Share	16.19
Working Capital	-3.82B

Cash Flow

In the last 12 months, operating cash flow was 15.38 billion and capital expenditures -1.32 billion, giving a free cash flow of 14.07 billion.

Operating Cash Flow	15.38B
Capital Expenditures	-1.32B
Depreciation & Amortization	3.55B
Net Borrowing	11.47B
Free Cash Flow	14.07B
FCF Per Share	n/a

Margins

Gross margin is 75.55%, with operating and profit margins of 32.56% and 23.92%.

Gross Margin	75.55%
Operating Margin	32.56%
Pretax Margin	27.90%
Profit Margin	23.92%
EBITDA Margin	40.51%
EBIT Margin	32.56%
FCF Margin	30.99%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	64.15%
Buyback Yield	3.80%
Shareholder Yield	3.80%
Earnings Yield	4.96%
FCF Yield	6.43%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.27 and a Piotroski F-Score of 5.

Altman Z-Score	3.27
Piotroski F-Score	5